We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
-9.52%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.45B
AUM Growth
-$260M
Cap. Flow
-$60.9M
Cap. Flow %
-4.19%
Top 10 Hldgs %
28.63%
Holding
250
New
52
Increased
74
Reduced
49
Closed
70

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$41M
2
AZN icon
AstraZeneca
AZN
+$33.5M
3
PFE icon
Pfizer
PFE
+$33.5M
4
TMUS icon
T-Mobile US
TMUS
+$24.8M
5
FDS icon
Factset
FDS
+$19.9M

Top Sells

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$56.1M
2
INFY icon
Infosys
INFY
+$39.4M
3
STX icon
Seagate
STX
+$30.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$30M
5
ACN icon
Accenture
ACN
+$29.6M

Sector Composition

Rank Sector Weight
1 Technology 16.61%
2 Healthcare 16.42%
3 Financials 12%
4 Industrials 11.87%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PWR icon
1
Quanta Services
PWR
$100B
$64.8M 4.46%
517,334
+2,694
+0.5% +$331K
UNH icon
2
UnitedHealth
UNH
$376B
$58.7M 4.04%
114,324
+9,060
+9% +$4.55M
FCX icon
3
Freeport-McMoran
FCX
$90B
$43.2M 2.97%
1,475,775
-32,227
-2% -$1.29M
MSFT icon
4
Microsoft
MSFT
$3.45T
$42.8M 2.94%
166,530
-52,875
-24% -$14.4M
KLAC icon
5
KLA
KLAC
$239B
$39.6M 2.72%
1,240,240
+1,220,120
+6,064% +$41M
PFE icon
6
Pfizer
PFE
$143B
$34.4M 2.37%
+656,776
New +$33.5M
RTX icon
7
RTX Corp
RTX
$290B
$34.4M 2.37%
357,525
+153,666
+75% +$14.8M
AZN icon
8
AstraZeneca
AZN
$263B
$33.7M 2.32%
+255,164
New +$33.5M
DVN icon
9
Devon Energy
DVN
$52.1B
$33.1M 2.28%
601,410
+19,143
+3% +$1.25M
TRV icon
10
Travelers Companies
TRV
$78.1B
$31.1M 2.14%
183,694
+49,099
+36% +$8.53M
LPLA icon
11
LPL Financial
LPLA
$28.3B
$29.5M 2.03%
159,686
+9,050
+6% +$1.72M
SYY icon
12
Sysco
SYY
$40.8B
$29.3M 2.02%
345,625
+144,894
+72% +$12.1M
HSY icon
13
Hershey
HSY
$35.5B
$28.9M 1.99%
134,489
+3,393
+3% +$739K
TSN icon
14
Tyson Foods
TSN
$20.4B
$27.9M 1.92%
323,645
+92,740
+40% +$8.31M
CTVA icon
15
Corteva
CTVA
$52.6B
$27.7M 1.9%
510,724
+64,435
+14% +$3.74M
ON icon
16
ON Semiconductor
ON
$31.8B
$25.9M 1.79%
515,378
+67,476
+15% +$3.76M
SNPS icon
17
Synopsys
SNPS
$74.4B
$25.8M 1.78%
85,031
+7,709
+10% +$2.33M
TMUS icon
18
T-Mobile US
TMUS
$185B
$25.6M 1.76%
+190,439
New +$24.8M
COST icon
19
Costco
COST
$422B
$25.2M 1.74%
52,636
+7,018
+15% +$3.56M
COR icon
20
Cencora
COR
$60.6B
$24.9M 1.71%
175,922
+15,643
+10% +$2.39M
NI icon
21
NiSource
NI
$21.3B
$23.9M 1.65%
810,650
+99,265
+14% +$3.01M
HPQ icon
22
HP
HPQ
$24.9B
$22.7M 1.56%
691,317
+445,201
+181% +$16.3M
WMB icon
23
Williams Companies
WMB
$87.5B
$22.2M 1.53%
711,018
+23,484
+3% +$811K
KIM icon
24
Kimco Realty
KIM
$17.2B
$21.9M 1.51%
1,106,356
+175,980
+19% +$4.04M
BLDR icon
25
Builders FirstSource
BLDR
$7.15B
$21.4M 1.47%
398,235
+21,979
+6% +$1.35M

Similar funds

Cookson Peirce & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Cookson Peirce & Co held 250 positions worth $1.45B, down 15% from $1.71B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cookson Peirce & Co withdrew a net $60.9M in Q2 2022, closing 70 positions and reducing 49 holdings. Its most notable exit was Infosys, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Cookson Peirce & Co opened a new position in AstraZeneca worth $33.7M.

  • Cookson Peirce & Co's largest Q2 2022 buy was AstraZeneca: 255,164 shares worth $33.7M.
  • Cookson Peirce & Co added most to KLA in Q2 2022, an estimated $41M increase.
  • Cookson Peirce & Co's biggest Q2 2022 reduction was Morgan Stanley, cutting an estimated $56.1M.
  • Cookson Peirce & Co fully exited Infosys in Q2 2022, selling an estimated $39.4M.
  • Cookson Peirce & Co's ten largest holdings make up 29% of its $1.45B portfolio in Q2 2022.
  • Cookson Peirce & Co opened 52 new positions and closed 70 in Q2 2022.
  • Cookson Peirce & Co's portfolio value fell 15% quarter-over-quarter to $1.45B.

Based on Cookson Peirce & Co's 13F filing for Q2 2022, filed 20 Jul 2022.